HealthDay - WEDNESDAY, Dec. 7 (HealthDay News) -- In November, the U.S. Food and Drug Administration revoked its approval of the drug Avastin for the treatment of breast cancer. But, a new study suggests that the drug can boost the survival of women with a specific type of aggressive breast tumor when used in conjunction with two other medications.

Reuters - According to a new look at past antidepressant trials, up to a fifth of patients on Cymbalta and similar medications may actually do worse than those given drug-free placebo pills.

Reuters - According to a new look at past antidepressant trials, up to a fifth of patients on Cymbalta and similar medications may actually do worse than those given drug-free placebo pills.

HealthDay - WEDNESDAY, Oct. 26 (HealthDay News) -- An experimental psoriasis treatment performed significantly better than the commonly prescribed medication methotrexate in a new clinical trial.

Reuters - Biogen Idec Inc's said on Wednesday its experimental multiple sclerosis drug BG-12 met the main goal of a closely watched clinical trial, sending its shares up 9 percent.

HealthDay - (HealthDay News) -- Over-the-counter medications may seem safer because they don't require a prescription. But they can still interact badly when alcohol enters the mix.

HealthDay - TUESDAY, Oct. 25 (HealthDay News) -- When used alone, the asthma medications known as long-acting beta-agonists are associated with an increased risk of serious complications, new research indicates.

HealthDay - TUESDAY, Oct. 25 (HealthDay News) -- Preliminary research suggests that a patch could deliver an AIDS drug to patients, but it's too early to know if it could work in animals, let alone humans.

Reuters - Eli Lilly and Co said it is withdrawing its sepsis drug Xigris from all markets after it failed to help patients live longer in a clinical trial.

Reuters - DaVita Inc, the biggest U.S. operator of dialysis clinics, said it is the subject of a government probe into payments for infusion drugs covered by the Medicaid health program for the poor in New York.

HealthDay - SUNDAY, Oct. 23 (HealthDay News) -- Older women who take nonsteroidal anti-inflammatory drugs -- such as aspirin or ibuprofen -- appear to have a lower risk of death from colorectal cancer than women who don't use these medications, a large new study suggests.

HealthDay - MONDAY, Oct. 24 (HealthDay News) -- For the millions of Americans on blood pressure-lowering drugs, a new study suggests that taking the pills at bedtime may be best.

AP - A government advisory body in the Czech Republic is working on a new law to legalize growing and consuming medical marijuana.

LiveScience.com - Use of medications to suppress stomach acid in infants has skyrocketed, but the trend is neither based in science nor beneficial to babies, a commentary suggests.

HealthDay - WEDNESDAY, Oct. 19 (HealthDay News) -- Although pregnant women who have high blood pressure face a higher risk that their baby will be born with birth defects, new research indicates that the medications typically used to treat the condition will not raise that risk any further.

HealthDay - MONDAY, Oct. 17 (HealthDay News) -- When it comes to telling the difference between candy and some medications, teachers are almost as likely to make an error as kindergartners, according to new research conducted by two enterprising elementary schoolers.

Reuters - U.S. health advisers said they were unconvinced that Teva Pharmaceutical Industries Ltd's Parkinson's drug Azilect slows the progression of the incurable disease.

Reuters - Walgreen Co on Monday offered to match or beat other pharmacies' costs in order to stay in Express Scripts Inc's program for U.S. military personnel and their families, as it tries to hold onto some of its business with the pharmacy benefits manager.

HealthDay - FRIDAY, Oct. 14 (HealthDay News) -- A growing number of American children are receiving psychiatric care in hospital emergency departments, particularly children who have no insurance or are covered by Medicaid.

Reuters - Shares of Depomed Inc fell as much as 29 percent to their lowest in a year, after the specialty pharmaceutical company said its experimental drug to treat menopausal hot flashes showed mixed results in a late-stage study.